+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmacyclics LLC - Strategic SWOT Analysis Review

FEATURED COMPANIES

  • Ambrilia Biopharma Inc
  • Aphios Corp
  • CTI BioPharma Corp
  • Pharming Group NV
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pharmacyclics LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The publisher’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights

Pharmacyclics LLC (Pharmacyclics), a subsidiary of AbbVie Inc, focus on the development and commercialization of small-molecule medicines for the treatment of cancer and immune-mediated diseases. The company’s marketed product includes Imbruvica is an once-daily, first-in-class bruton's tyrosine kinase (BTK) inhibitor developed for the treatment of patients with chronic lymphocytic leukemia, mantle cell lymphoma, waldenstrom's macroglobulinemia, marginal zone lymphoma and chronic graft-versus-host disease. Its products candidate in clinical development includes Imbruvica BTK inhibitor intended for the treatment of chronic lymphocytic leukemia, small lymphocytic lymphoma, mantle cell lymphoma, diffuse large b-cell lymphoma, follicular lymphoma, graft versus host disease, mature B-cell non-hodgkin lymphomas and solid tumors, among others. Pharmacyclics is headquartered in Sunnyvale, California, the US.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the publisher’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Ambrilia Biopharma Inc
  • Aphios Corp
  • CTI BioPharma Corp
  • Pharming Group NV
  • MORE
Section 1 - About the Company
  • Pharmacyclics LLC - Key Facts
  • Pharmacyclics LLC - Key Employees
  • Pharmacyclics LLC - Major Products and Services
  • Pharmacyclics LLC - History
  • Pharmacyclics LLC - Company Statement
  • Pharmacyclics LLC - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Pharmacyclics LLC - Business Description
  • Pharmacyclics LLC - SWOT Analysis
  • SWOT Analysis - Overview
  • Pharmacyclics LLC - Strengths
  • Pharmacyclics LLC - Weaknesses
  • Pharmacyclics LLC - Opportunities
  • Pharmacyclics LLC - Threats
  • Pharmacyclics LLC - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Pharmacyclics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Pharmacyclics LLC, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Pharmacyclics LLC, Recent Deals Summary
Section 4 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Pharmacyclics LLC, Key Facts
  • Pharmacyclics LLC, Key Employees
  • Pharmacyclics LLC, Major Products and Services
  • Pharmacyclics LLC, History
  • Pharmacyclics LLC, Other Locations
  • Pharmacyclics LLC, Key Competitors
  • Pharmacyclics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Pharmacyclics LLC, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Pharmacyclics LLC, Recent Deals Summary
List of Figures
  • Pharmacyclics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Pharmacyclics LLC, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Note: Product cover images may vary from those shown

Loading
LOADING...

A selection of companies mentioned in this report includes:

  • Pharming Group NV
  • Novartis Vaccines and Diagnostics Inc
  • CTI BioPharma Corp
  • Aphios Corp
  • Ambrilia Biopharma Inc
Note: Product cover images may vary from those shown
Adroll
adroll